Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
10/2000
10/12/2000WO2000059882A1 Anticancer calcium channel blockers
10/12/2000WO2000059880A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2000WO2000059876A1 3-amidinobenzenesulfonamide derivatives, medicinal compositions containing the same and intermediates in the production thereof
10/12/2000WO2000059874A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE
10/12/2000WO2000059304A1 Compositions and methods for preventing and treating sexual dysfunctions
10/12/2000WO1999064039A9 Bradykinin antagonists
10/12/2000WO1998025597A3 Method for treating and preventing heart failure and ventricular dilatation
10/12/2000CA2369238A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2000CA2368623A1 3-amidinobenzenesulfonamide derivatives, medicinal compositions containing the same and intermediates in the production thereof
10/12/2000CA2366264A1 Novel amide derivatives as inhibitors of matrix metalloproteinases, tnf-.alpha., and aggrecanase
10/11/2000EP1043314A1 Novel dihydropyridine derivative
10/11/2000EP1043310A1 Biphenylamidine derivatives
10/11/2000EP1042297A1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
10/11/2000EP1042290A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
10/11/2000EP1042279A1 Substituted beta-alanines
10/11/2000EP1041980A1 Acyl guanidine sodium/proton exchange inhibitors and method
10/11/2000EP0918822A4 Copolymers of propylene with polymerizable hindered amine light stabilizers
10/11/2000EP0703971B1 Use of n,n-diacetic alpha-alanine and its salts as biodegradable complexing agents for alkaline earth and heavy metal ions in cleaning compositions for dishwashing
10/11/2000CN1269799A Piperidinylmethyloxazolidinone derivative
10/11/2000CN1269790A Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for production and use thereof as medicaments
10/11/2000CN1269362A 1,4-dichloropyridine-3,5-carboxylic-acid derivatives and preparation method thereof
10/11/2000CN1269359A Antimer pure acetacetates, its preparation method and use
10/11/2000CN1269358A Amino-butenate compound and preparation method thereof
10/11/2000CN1269357A Benzal compound and preparation method
10/11/2000CN1057294C Preparation of 3,4,4-trisubstituted-piperidinyl-N-alkycarboxylates and intermediates
10/11/2000CN1057292C Dicyclic compound, medicinal composition containing same and use thereof
10/10/2000US6130234 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists
10/10/2000US6130226 Immunotherapeutic agents
10/10/2000US6130222 Analgesics
10/10/2000US6130221 Pharmaceutical agents that impede the initiation and progression of primary and secondary DMS disruptions
10/10/2000US6130220 Enzyme inhibitors
10/05/2000WO2000058305A1 Novel compounds
10/05/2000WO2000058294A1 Antibacterial agents
10/05/2000WO2000058284A1 Method of producing 3,4-dihydroprolines and 3,4-dehydropiperidines
10/05/2000WO2000012476A9 Processes for preparing 2-piperidineethanol compounds
10/05/2000CA2361366A1 Novel compounds
10/04/2000EP1040103A1 Anilide derivative, production and use thereof
10/04/2000EP0766672B1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors
10/04/2000EP0765311B1 4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl)piperidines, tetrahydropyridines or piperazines
10/04/2000CN1268941A Method for producing particles of pyrithione salts
10/04/2000CN1268889A Novel process for obtg. intermediates
10/04/2000CN1057086C Phenylsulfonyl ureas, process for preparing same, and use as herbicide, herbicide composition contg. same
10/03/2000US6127568 Phenylacetic acid derivatives, preparation thereof and intermediates thereof, and compositions containing them
10/03/2000US6127427 Active hydroxamic acids involved in tissue degradtion and also are inhibitors of the release of tumour necrosis factor from cells; rheumatoid arthritis, osteoarthritis, osteopenias such as osteoporosis, periodontitis, vision defects
10/03/2000US6127423 Phenylamidine derivatives, a process for preparing the same and their use as medicaments
10/03/2000US6127384 Compounds, compositions and methods for treatment of hepatitis C
10/03/2000US6127372 Sulfonamide inhibitors of aspartyl protease
10/03/2000US6127354 For treatment of growth disorders or to stimulate production of wool or milk
10/03/2000US6126861 Stabilizer composition
10/03/2000US6126736 Pigment stabilization
09/2000
09/28/2000WO2000056730A1 PROCESS FOR PREPARING [S-(R*,S*)] -β -[[[1-[1-OXO-3- (4-PIPERIDINYL) PROPYL] -3-PIPERIDINYL] CARBONYL] AMINO] -3- PYRIDINEPROPANOIC ACID AND DERIVATIVES
09/28/2000WO2000056713A1 Antiviral agents
09/28/2000WO2000056712A1 Sulfonamide derivatives as 5-ht7 receptor antagonists
09/28/2000WO2000056704A1 Hydroxamic and carboxylic acid derivatives
09/28/2000WO2000056335A1 Methods for treating neurodegenerative disorders using aspartyl protease inhibitors
09/28/2000WO2000024396A9 Treatment of disorders of the outer retina
09/28/2000DE19913699A1 Verfahren zur Herstellung von 3,4-Dihydroprolinen und 3,4-Dehydropiperidinen A process for the preparation of 3,4-and 3,4-Dihydroprolinen Dehydropiperidinen
09/28/2000CA2368024A1 Process for preparing [s-(r*,s*)]-.beta.-[[[1-[1-oxo-3-(4-piperidinyl)propyl]-3-piperidinyl]carbonyl]amino]-3-pyridinepropanoic acid and derivatives
09/28/2000CA2367963A1 Hydroxamic and carboxylic acid derivatives
09/28/2000CA2367112A1 Methods for treating neurodegenerative disorders using aspartyl protease inhibitors
09/27/2000EP1038872A1 4-Phenyl-4-heteroarylpiperdine derivatives as opioid receptor ligands
09/27/2000EP1038868A2 Sulfonamides as antiviral agents
09/27/2000EP1038867A1 Process for the purification of N-substituted lactames, with acidic macroporous cation exchange resins
09/27/2000EP1037878A2 Metabotropic glutamate receptor antagonists for treating central nervous system diseases
09/27/2000EP1037876A1 Biphenyl derivatives as pharmaceuticals
09/27/2000EP1037875A1 Method for producing salts of cyclic amidines
09/27/2000EP1037636A1 Inhibition of membrane-associated viral replication
09/27/2000EP0918792B1 Dipeptide benzamidine as a kininogenase inhibitor
09/27/2000CN1268116A 3-amidinoaniline derivatives activated blood coagulation factor X inhibitors, and intermediates for producing both
09/27/2000CN1267669A Separation of Amlodipine antimer
09/26/2000US6124462 Preparing arylamine and biaryls
09/26/2000US6124354 Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation
09/26/2000US6124323 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists
09/26/2000US6124318 A neurotrophic drug treating or preventing a disease involving neuronal degeneration such as senile dementia of the alzheimer type
09/26/2000US6124317 2-substituted piperidine analogs and their use as subtype-selective NMDA receptor antagonists
09/26/2000US6124316 Compounds which are specific antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools
09/26/2000US6124296 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
09/26/2000US6124283 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
09/26/2000US6124277 Antithrombotic agents
09/26/2000US6124251 Toilet bowl cleaning tablet
09/21/2000WO2000055154A1 Modified amino-acid amides as cgrp antagonists
09/21/2000WO2000055126A2 N-cyanomethylamides as protease inhibitors
09/21/2000WO2000055125A2 N-cyanomethyl amides as protease inhibitors
09/21/2000WO2000039077A3 Thyroid receptor ligands
09/21/2000DE19912638A1 Naphthylcarbonsäureamid-substituierte Sulfonamide Naphthylcarbonsäureamid-substituted sulfonamides
09/21/2000CA2368148A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2368122A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2361939A1 Modified amino acid amides, pharmaceutical compositions containing these compounds and processes for preparing them
09/20/2000EP1036062A1 Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors
09/20/2000CN1267294A Benzo (5,6) cyclohepta (1,2-b) pyridine derivs. for inhibition of farnesyl-protein transferase
09/20/2000CN1056609C Benzoyl guanidines, their production and their use in medicinal compositions
09/20/2000CN1056606C Substd. dihydro-pyridine dicarboxylate, its preparing method, medicine contg. same and use thereof
09/20/2000CN1056605C Compounds as selective human NK 3-receptor antagonists and their use
09/19/2000US6121453 Resolution of threo-methylphenidate
09/19/2000US6121281 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
09/19/2000US6121273 Isomerase inhibitors effective against neurological disorders, i.e. parkinson's disease, alzheimer's disease, amyotrophic lateral sclerosis; side effect reduction
09/19/2000US6121272 Bidentate metalloprotease inhibitors
09/19/2000US6121262 Neurokin (tachykinin) antagonists
09/19/2000US6120777 High fluorescence specific immune enhancing factor and methods of use for same
09/14/2000WO2000053545A1 Process for the synthesis of dihydropyridones
1 ... 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 ... 380